Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$4.65M |
| 2 |
Peloton Interactive
PTON
|
+$2.77M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$2.18M |
| 4 |
Capital One
COF
|
+$1.26M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$2.74M |
| 2 |
SI
Silvergate Capital Corporation
SI
|
+$2.36M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$2.04M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$1.37M |
| 5 |
Ovintiv
OVV
|
+$975K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.12% |
| 2 | Financials | 20.01% |
| 3 | Energy | 10.57% |
| 4 | Industrials | 9.11% |
| 5 | Technology | 8.84% |
Similar funds
Samantha McLemore's Q1 2023 Portfolio in Review
As of Q1 2023, Samantha McLemore held 44 positions worth $224M, up 9% from $206M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Samantha McLemore's Q1 2023 filing shows 1 new, 11 increased, 18 reduced and 3 closed positions. Its largest new stake was UBS Group: 222,800 shares worth $4.75M. The largest sale was DXC Technology, an estimated $2.74M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 32% a quarter earlier, followed by Financials and Energy.
- Samantha McLemore's largest Q1 2023 buy was UBS Group: 222,800 shares worth $4.75M.
- Samantha McLemore added most to Peloton Interactive in Q1 2023, an estimated $2.77M increase.
- Samantha McLemore's biggest Q1 2023 reduction was DXC Technology, cutting an estimated $2.74M.
- Samantha McLemore fully exited Silvergate Capital Corporation in Q1 2023, selling an estimated $2.36M.
- Samantha McLemore's ten largest holdings make up 40% of its $224M portfolio in Q1 2023.
- Samantha McLemore opened 1 new position and closed 3 in Q1 2023.
- Samantha McLemore's portfolio value rose 9% quarter-over-quarter to $224M.
Based on Patient Capital Management's 13F filing for Q1 2023, filed 15 May 2023.